Trial Profile
A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and Safety of a New Therapy With Adipose-derived Autologous Stem Cells for the Treatment of Complex Perianal Fistulas in Patients Without Inflammatory Bowel Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs CX 401 (Primary) ; Fibrin
- Indications Rectal fistula
- Focus Registrational; Therapeutic Use
- Acronyms FATT1
- Sponsors Cellerix
- 18 Sep 2014 New trial record